An important theme that has emerged during the past 5 years is that Ras transformation is mediated by signaling activities that are much more complex than originally envisioned (Marshall, 1996; Khosravi-Far et al., 1997; Campbell et al., 1998) . Considerable biological, biochemical and genetic evidence support the importance of the Raf serine/threonine kinase a key eector of Ras function. However, the evidence that Ras has a life beyond simply activating Raf is strong and continues to mount. Instead, our current model proposes that Ras employs a spectrum of functionally diverse downstream eectors to cause its diverse actions on cell proliferation, dierentiation and apoptosis. Among these Raf-independent signaling pathways are those that connect Ras with speci®c members of the Rho family of small GTPases. Since Rho family proteins are regulators of actin organization, gene expression, and cell cycle progression, it is likely that Rho family proteins will contribute signi®cantly to the actions of oncogenic Ras. The Rho family of proteins have been the subject of a number of excellent reviews (Symons, 1996; Narumiya, 1996; Van Aelst and D'Souza-Schorey, 1997 ). Therefore, in this review we will emphasize the involvement of Rho family proteins in the regulation of cell proliferation and Ras transformation. Despite our wealth of knowledge on these small GTPases, we are clearly in the early days of comprehending the complex involvement of these small GTPases in regulating normal and neoplastic cell biology. More excitement is certain to follow as we continue to develop and revise, or discard, our current models and concepts.
Rho family proteins are members of the Ras superfamily of small GTPases
The Ras superfamily of small (20 ± 25 kDa) GTPases (480 mammalian members) can be categorized into at least nine distinct branches. These include the Ras, Rab, Rho, Ran, Rheb, Rad/Gem, Rin/Rit and Arf families. Rho family proteins constitute one of the three major branches of the Ras superfamily and its members share approximately 30% amino acid identity with the four Ras proteins (Chardin, 1993) . Presently, at least 14 mammalian Rho family proteins have been identi®ed: RhoA, RhoB, RhoC, RhoD, RhoE/Rnd3, Rnd1/Rho6, Rnd2/Rho7, RhoG, Rac1, Rac2, Rac3, Cdc42, TC10 and TTF that share signi®cant (ranging from 50 ± 90%) amino acid identity with each other (Ridley, 1996) (Figure 1a ). Two mammalian isoforms of Cdc42 have been identi®ed from brain (B) or placenta (P).
Much of our knowledge of Rho family protein function has been derived primarily from the studies of Rac1, RhoA and Cdc42 and each exhibits distinct cellular functions. A recent report indicates that RhoD possesses functions distinct from these three proteins (Murphy et al., 1996) . Sequence comparisons suggest that RhoE and TTF may also share functional relationships, whereas TC10 and RhoG are anticipated to be most related in function to Cdc42 and Rac1, respectively (Figure 1b) . Recent observations that Rho/ Rnd3 or Rnd1 causes a disruption of stress ®bers members, are likely to occur in the future. Finally, although RhoA, RhoB and RhoC are likely to share common functions in regulating stress ®ber formation , they dier in subcellular location (Adamson et al., 1992) , regulation of expression (Jahner and Hunter, 1991; Fritz et al., 1995) and posttranslational lipid modi®cation (Adamson et al., 1992; Lebowitz et al., 1995) . Thus, even closely related members are likely to exhibit unique roles as well.
Like Ras, Rho family proteins function as GTP/ GDP regulated switches that cycle between active GTP-and an inactive GDP-bound forms (Figure 2 ) (Ridley, 1996) . This cycle is regulated by three distinct classes of regulatory proteins. First, Rho guanine nucleotide exchange factors (GEFs; also referred to as Dbl homology proteins) serve as activators and stimulate the replacement of GDP by GTP . To date, over 20 Dbl homology proteins a Rho family of small GTPases and transformation I Zohn et al have been identi®ed, and the majority were initially discovered as transforming proteins in NIH3T3 focusformation assays (e.g., Dbl, Vav) ( Figure 3) . Second, at least 16 Rho GTPase activating proteins (GAPs) have also been identi®ed that serve as negative regulators of Rho family protein function by stimulating their intrinsic GTPase activities (Cerione and Zheng, 1996) . Some GAPs show preferential stimulation of speci®c Rho family proteins. A third class of Rho regulators are the Rho GDPdissociation inhibitory factors (RhoGDIs). The ®rst RhoGDI was originally identi®ed as an inhibitor of Rac GDP dissociation (Ueda et al., 1990) and subsequently, of Cdc42 and Rac as well (Abo et al., 1991; Leonard et al., 1992) . This ubiquitously expressed, cytosolic protein, was later shown to interfere with both intrinsic and GAP-stimulated GTP hydrolysis of Rac and Cdc42 (Chuang et al., 1993; Hart et al., 1992) . Thus, RhoGDI can perturb Rho GDP/GTP cycling via two distinct mechanisms. Finally, RhoGDIs also serve an important role in regulating the association of Rho family proteins with membranes (Takai et al., 1995) . A cytosolic complex with RhoGDI is disrupted during Rho membrane translocation and activation by GEFs. Two additional RhoGDIs include the hematopoietic cell speci®c D4-GDI/LY-GDI (Lelias et al., 1993; Scherle and Staudt, 1993) and RhoGDIg/RhoGDI-3, which is preferentially expressed in brain, pancreas and other tissues (Adra et al., 1997; Zalcman et al., 1996) .
Several regulators of Rho GDP/GTP cycling appear to function as multifunctional regulators. For example, BCR and ABR each possess distinct catalytic domains that serve as both Rho GEFs and GAPs (Chuang et al., 1995) (Figure 3 ). In addition, some Rho GAPs may also serve as downstream eectors (e.g., N-chimaerin and the p85 subunit of phosphoinositide-3-OH kinase (PI3K)) Zheng et al., 1994a) . Although RasGRFs and SOS have been shown to function as Ras GEFs, the presence of tandem DH/PH domains in these molecules suggests that they may possess a Rho family GEF function which is distinct from their Ras GEF function (Nimnual et al., 1998; Fan et al., 1998) . Finally, one Dbl family protein (Trio) possesses two distinct DH domains and each shows distinct GEF activities.
Like Ras, Rho family GTPases share high sequence similarity, especially in the core GTP binding sequences, and diverge primarily at their COOHtermini. The x-ray and NMR structures of truncated forms of Rac1-GMPPNP, Cdc42-GDP, G14V RhoA-GDP and RhoA-GTPgS have recently been solved Feltham et al., 1997; Ihara et al., 1998; Rittinger et al., 1997; Wei et al., 1997) . Like Ras these Rho family GTPases share a common a/b fold with the core GTP-binding domain as a conserved structural unit. In contrast to Ras, the Rho subfamily contains an insert of 13 amino acids in a region between b5 and a4 of H-Ras. One exception, however, is TTF, which contains a smaller insert b Figure 1 Sequence comparison of Rho family proteins. (a) To date, at least 14 distinct mammalian Rho family proteins have been described. A multiple sequence alignment of human Rho family proteins and H-Ras was generated using the dynamic algorithm alignment program ClustalW (Thompson et al., 1994) . A pro®le alignment of the Rac1 primary sequence containing Rac1 secondary structural elements and the remaining Rho family proteins was initially constructed. The primary sequence of H-Ras was then added before the ®nal multiple sequence alignment was produced. All alignments were carried out using PAM series protein weight matrices. The ClustalW multiple sequence alignment was shaded using Boxshade 3.2 (Thompson et al., 1994) . Residues that are conserved in greater than 50% of sequences at a given sequence position are colored blue, while residues that are similar are colored yellow. (b) The sequence alignment described above was used to construct the Rho dendrogram. The branch lengths in the dendrogram are proportional to the estimated divergence along each branch. Rnd3/Rho8 diers from RhoE only in having an additional 15 amino acid NH 2 -terminal extension (Nobes et al., 1998) consisting of 7 amino acids. In Rac1 and RhoA, the insert consists of two alpha helices followed by an extended loop. The insert represents a highly charged surface, is mobile and exposed. However, Cdc42 contains only one helix in the insert. Moreover, the insert appears to form a compact loop structure that forms contacts with the loop between b4 and a3. It is not clear whether these dierences represent differences between X-ray and NMR methods or whether the fact that the structure of Rac1 was solved on a F87S mutant that may alter the structure and contacts between the insert and the b4/a3 loop. NMR studies indicate that the conformation of the insert is not sensitive to the binding of GTP versus GDP.
Like Ras, the conformation of the switch I and switch II domains is sensitive to the binding of GTP versus GDP and both appear to be dynamic structures. However, in contrast to Rac1, helix two in the switch II domain of Cdc42 is absent. Interestingly, NMR chemical shift mapping of Cdc42-GDP and Cdc42-GMPPCP suggest the existence of an additional switch region comprised of b4/a3 and a3 (Feltham et al., 1997) .
Rho family proteins are regulators of diverse cellular processes
Rho family proteins have been implicated in the regulation of a diverse and extensive spectrum of cellular processes. Most prominent among these are their eects on the organization of the actin cytoskeleton. Rho proteins also initiate signaling cascades that cause activation of a variety of transcription factors. Hence, Rho-mediated changes in the actin organization or in gene expression may regulate many of the cellular processes associated with Rho protein function. These include regulation of cell shape, cell attachment, cell motility and invasion, cellcell interactions, cell proliferation, dierentiation and apoptosis. Below, we summarize our current knowledge regarding the involvement of Rho proteins in controlling speci®c cellular processes.
Rho proteins are regulators of actin cytoskeletal organization
The best characterized function of Rho family proteins involves their regulation of speci®c ®lamentous F-actin organization. Actin ®laments are components of one of the three major cytoskeletal protein networks that determine cell shape, movement and regulate cellular processes: actin ®laments, microtubules and intermediate ®laments. The actin cytoskeleton is a highly dynamic cytoplasmic structure that is reshaped and reformed in response to diverse extracellular signals.
In ®broblasts, polymerized actin is assembled into a variety of distinct structures. Lamellipodia are curtainlike extensions that consist of thin protrusive actin sheets. Membrane rues represent lamellipodia that have lifted from the substratum at the leading edge of cells. Actin stress ®bers consist of actin bundles that traverse the cell and promote cell attachment to the extracellular matrix via focal adhesions. Focal adhesions consist of integrins and cytoplasmic proteins such as vinculin and talin. Filopodia are thin, ®nger-like cytoplasmic extensions that contain tight actin bundles and may be involved in the recognition of the extracellular environment . Speci®c Rho family proteins are regulators of distinct changes in these actin-based structures, as well as others (e.g., tight junctions in polarized epithelial cells) (Nusrat et al., 1995) , in ®broblasts and other cell types. Fam et al., 1997; Schuebel et al., 1996; Henske et al., 1995; Gebbink et al., 1997; Alam et al., 1997) . All share a Dbl homology (DH) followed by a pleckstrin homology (PH) domain. Beyond the tamdem DH/PH domains, each Dbl family protein possesses distinct catalytic (Ras GEF, Rho GAP) or protein-protein or protein-lipid interaction motifs [Src homology 2 and 3 (SH2 and SH3), cysteine-rich zinc-binding domains (CRDs)]. A Rho GEF activity has been de®ned for most, but not all, members of this family. Whereas some exhibit very speci®c activity, others serve as activators of multiple Rho family proteins. For example, FGD1 is an activator of Cdc42, while Vav can activate Rac1, RhoA and Cdc42 The ®rst clues that Rho family proteins regulate actin organization were provided by studies using C3 toxin from Clostridium botulinum, an inhibitor of RhoA, B and C function (Chardin et al., 1989) and by microinjection analyses using mutant Rho family proteins (Paterson et al., 1990; Nobes and Hall, 1995) . These studies demonstrated that speci®c Rho family proteins are components of signaling pathways that induce unique morphological changes involving rearrangements of F-actin. RhoA, Rac1 and Cdc42 control distinct changes in the actin cytoskeleton and distinct cellular structures. Furthermore, they can act in concert in cascades that link their activities. Constitutively activated Cdc42 caused induction of ®lopodia in Swiss 3T3 ®broblasts as well as the activation of Rac Kozma et al., 1995) . Activated Rac1 in turn caused the induction of lamellipodia and membrane ruing, and the activation of Rho . Activated RhoA caused the formation of stress ®bers and focal adhesions . Both Rac and Cdc42 also regulate formation of focal complexes distinct from those caused by RhoA. A second cascade of small GTPases involves the ability of oncogenic Ras to activate Rac and subsequently Rho . GTPase cascades that involve Rho family proteins have also been described in the yeasts S. cerevisiae and S. pombe (reviewed in Chant and Stowers, 1995) .
Although a Cdc424Rac4Rho cascade has also been seen in other cell types (Allen et al., 1997) , variations on this theme, involving separate pathways or feedback loops, have also been observed. For example, Cdc42 was shown to inhibit, rather than promote, stress ®ber formation in other cell types (Kozma et al., 1995; Qiu et al., 1997) . Activated Rac did not induce actin stress ®ber formation in MDCK epithelial cells (Ridley et al., 1995) . Inactivation of Rho caused activation of Cdc42 and Rac in N1E-115 neuroblastoma cells (Kozma et al., 1997) . These observations, when taken together with the fact that each Rho family can be activated by distinct signals, re¯ect the versatility of Rho family proteins in orchestrating dierent cellular processes in dierent situations and cell types.
Finally, the precise links between these GTPase cascades have not been established. However, based on the involvement of Dbl family-related proteins (CDC24) in the activation of Cdc42 in yeast pathways (Zheng et al., 1994b) , it is logical that Dbl family proteins will serve as intermediates between GTPases. GAPs and GDIs may also facilitate these GTPase cascades. Figure 4 Rho family proteins are regulators of signaling pathways that regulate the organization of the actin cytoskeleton. Cdc42, Rac1 and RhoA function as downstream components of signaling pathways initiated by ligand-stimulated G protein-coupled serpentine receptors (SRs), receptor tyrosine kinases (RTKs) or integrin receptors (IRs). Cdc42, Rac1 and RhoA each modulate distinct changes in actin organization. At least two GTPase cascades have been identi®ed that regulate actin reorganization. One involves oncogenic Ras activation of Rac1, then Rac1 activation of RhoA. A second involves Cdc42 activation of Rac1 and RhoA. These hierarchies of small GTPases may vary in dierent cell types Like Ras, Rho family proteins also serve as GDP/ GTP-regulated relay switches that transmit extracellular ligand-mediated signals that promote changes in actin structures ( Figure 4 ). It had been observed previously that lysophosphatidic acid (LPA), bombesin and bradykinin each bind to GPCRs to activate the formation of ®lopodia, membrane rues and stress ®bers. Rho family proteins were subsequently implicated in these processes . For example, LPA stimulation of actin stress ®bers formation and the assembly of focal adhesion complexes in Swiss 3T3 cells was blocked by C3 toxin .
PDGF stimulation of its receptor, a transmembrane tyrosine kinase, causes membrane ruing which was blocked by dominant negative Rac . Dominant negative Cdc42 blocked the formation of ®lopodia induced by bradykinin . Finally, insulin-or hepatocyte growth factor-induced membrane ruing in KB human epidermoid carcinoma cells was dependent on Rac or Rho, respectively (Nishiyama et al., 1994) . There is evidence that PI3K may link PDGF-and insulinmediated signaling to Rac activation and induction of membrane ruing (Kotani et al., 1994; Wennstrom et al., 1994; Nobes and Hall, 1995) .
In general, speci®c Rho family proteins show the same eects on actin organization in dierent cell types. However, some cell type dierences have been observed. For example, Rac and Rho cause distinct membrane ruing response in KB human epithelial carcinoma cell lines (Nishiyama et al., 1994) . Whereas Rho causes neurite retraction, Rac causes neurite extension in NIE-115 neuroblastoma cells. Other members of the Rho family are also regulators of additional actin cytoskeletal rearrangements and cellular processes. For example, transient expression of activated RhoD in a variety of cell types caused rearrangements of the actin cytoskeleton and cell surface and involved the formation of long thin F-actin containing membrane processes together with the disassembly of stress ®bers and focal adhesions. These cytoskeletal changes corresponded with regulated endosome motility and distribution (Murphy et al., 1996) . RhoG has been reported to cause a Rac-dependent membrane ruing in Swiss 3T3 cells (Roux et al., 1997) . Finally, activated Rnd1 and RhoE/Rnd3 has been reported to cause a disruption of stress ®bers (Nobes et al., 1998; Guasch et al., 1998) . Figure 5 Rho family proteins are regulators of mitogen-activated protein kinase cascades. At least three distinct MAPK modules have been identi®ed and involve a cascade of a MAPK kinase kinase (MAPKKK; also MEKKs), a MAPK kinase (MAPKK; also MKKs) and a MAPK. Rac and Cdc42 have been shown to be activators of pathways that lead to the activation of the JNK and p38 MAPK modules (reviewed in Vojtek and Cooper, 1995; Treisman, 1996) . Although several kinases have been implicated as Rac/Cdc42 eectors (e.g., PAKs, MLKs, MEKKs), the precise link(s) between Rac and Cdc42 and these cascades is presently not known. Ras activates ERKs via a Raf-dependent pathway, and JNKs and p38 MAPKs via a Raf-dependent pathway that involves Rac/Cdc42. Activated MAPKs in turn regulate a variety of substrates that include nuclear transcription factors (reviewed in Treisman, 1996) ; (Wang and Ron, 1996; Zervos et al., 1995) . Note that common transcription factor targets are shared by the dierent MAPKs Rho family proteins are also associated with processes that involve the actin cytoskeleton in other organisms. The regulation of cytoskeletal organization by Rho family members is evident from genetics studies in yeast and Drosophila. Yeast Cdc42 has been demonstrated to coordinate polarization of the actin cytoskeleton during cell division by budding, and involves a cascade of other small GTPases (BUD1/ RSR1 and RHO proteins) (reviewed in Chant and Stowers, 1995) . In Drosophila, Drac1 is required to assemble actin at adherens junctions of the wing disc epithelium, while Dcdc42 is involved in the regulation of polarized cell shape during various stages of wing disc development (Eaton et al., 1995) . Studies have also implicated a requirement for Rho family proteins during cytokinesis in sand dollar (Mabuchi et al., 1993) Xenopus (Kishi et al., 1993; Drechsel et al., 1996) , Dictyostelium (Larochelle et al., 1996) and mammalian cells (Madaule et al., 1998) .
Rho family proteins are regulators of gene expression
In addition to their involvement in regulation of cytoskeletal organization, it has been shown that Rho family proteins regulate protein kinase cascades that control the activity of a variety of nuclear transcription factors ( Figure 5 ). To date, at least three distinct mitogen-activated protein kinase (MAPK) cascades have been identi®ed in mammalian cells and more are likely to be discovered (Treisman, 1996) . The p42 and p44 extracellular signal regulated kinases (ERKs; also called p42 and p44 MAPKs), Jun NH 2 -terminal kinases (JNKs) and p38/HOG kinases are distinct kinase cascades activated by distinct small GTPases. ERKs are activated by many mitogenic stimuli, whereas JNK and p38 are more commonly activated by cellular stress (heat shock, ionizing radiation, etc.) and in¯ammatory cytokines.
These cascades involve kinase modules where a MAPK kinase kinase (or MEKK) causes activation of a MAPK kinase (or MKK), which in turn activates a MAPK. The activated MAPKs have a variety of targets and include various Ets domain, bZIP and MADS box containing transcription factors reviewed in Treisman, 1996) . Although we have depicted each MAPK module as a separate linear array, there is cross talk between these cascades, as well as branch points and feedback loops within each module emphasizing the complex nature of signaling pathways.
Constitutively activated Rac1 and Cdc42, but not RhoA, are activators of JNKs (also called stressactivated protein kinases, or SAPKs) and p38/HOGs, but not the p42 and p44 ERKs (Coso et al., 1995; Minden et al., 1995; Olson et al., 1995; Bagrodia et al., 1995a; Zhang et al., 1995) . However, RhoA can activate JNK in some cells (Teramoto et al., 1996b) and RhoG is also an activator of JNK, but not ERK (Roux et al., 1997) . JNK in turn activates the ATF-2 and Jun nuclear transcription factors. ATF-2 and Jun can dimerize with other transcription factors to stimulate transcription from promoters containing AP-1 and related DNA sequences (e.g., the c-jun promoter) ( Figure 6 ) (Karin, 1995) . Although Rac, RhoA and Cdc42 are not activators of ERKs, it has been observed that they can indirectly modulate ERK activity in 293 cells (Luttrell et al., 1997) . Dominant negative Rac2 was found to impair Ras activation of ERK2, whereas activated RhoA, Rac2 and Cdc42 Figure 6 Rho family proteins are regulators of genes that control cell growth, dierentiation and apoptosis. Rho family proteins regulate the activity of genes that regulate cell proliferation and apoptosis (reviewed in Treisman, 1996) . RhoA, Rac1 and Cdc42 activate SRF , which forms a complex with ternary complex factors (e.g., Elk-1) at the serum response DNA element found in the promoter sequences of c-fos and other early response genes. RhoA and Rac/Cdc42 are believed to activate SRF through distinct pathways. Rac1/Cdc42 (and RhoA in some cells) activate JNK, which in turn can activate the Jun, ATF-2 and Elk-1 nuclear transcription factors. Activated c-Jun:ATF-2 heterodimers stimulate AP-1 like DNA elements in various promoters that regulate c-jun and other genes. Rac1 activates NF-kB by as yet unknown pathways that involve production of superoxide and phosphorylation and inactivation of IkB (Perona et al., 1997) . Among these NF-kB-responsive genes are those that have an anti-apoptotic function (Baichwal and Baeuerle, 1997) . Transduced and mutated versions of cellular Fos, Jun and NF-kB sequences were identi®ed as potent oncogene proteins responsible for the highly oncogenic properties of retroviruses (Bishop, 1991) . Thus, these Rho family mediated changes in gene expression are likely to contribute to the growth promoting actions of these small GTPases synergistically enhanced Raf activation of ERK2. How Rho family proteins may modulate ERK2 activation is not presently known. Furthermore, this crosstalk may not occur in all cell types, since we have not observed this in NIH3T3 cells . Oncogenic Ras activates ERKs via Raf and JNK and p38 via a Raf-independent pathway(s) (Minden et al., 1994; Olson et al., 1995; Clark et al., 1997) that are likely to involve Rac/Cdc42.
RhoA, Rac1 and Cdc42 have been shown to activate the transcription factor SRF (serum response factor) by as yet unde®ned signaling pathways (Whitmarsh et al., 1995) . SRF cooperates with ternary complex factors (TCFs; Elk-1 and SAP1/2) and the serum response DNA elements found in certain promoters such as the c-fos promoter and many other growth factor-regulated promoters (Marais et al., 1993) . TCFs are activated by the Raf4MEK4MAPK pathway ( Figure 6 ). Interestingly, Rac and Cdc42 activation of SRF is not dependent on Rho indicating that Rho family proteins utilize distinct pathways to activate SRF . Thus, the Cdc424Rac4Rho cascade that regulates actin structure is clearly distinct from pathways that regulate SRF. Again, cross-talk at the level of transcription factors is also seen. For example, Elk-1 can also be activated by JNK and p38.
Rho family proteins have also been implicated in the regulation of NF-kB. NF-kB recognizes DNA elements found in a wide variety of promoters (Baeuerle and Baltimore, 1996) . In one study, Finkel and colleagues found that activated Rac1, but not Cdc42, strongly stimulated NF-kB in HeLa cells (Sulciner et al., 1996) . Interleukin 1 b-stimulated NF-kB was also dependent on Rac function. However, a second study found that Rac1, RhoA and Cdc42 stimulated NF-kB by a mechanism that involves phosphorylation of IkB to promote NF-kB translocation to the nucleus (Perona et al., 1997) . Consistent with this second study, we have found that a variety of Dbl family proteins that are not activators of Rac (e.g., Dbl and Dbs) also activate NFkB .
Ras activation of JNK and NF-kB has been shown to be mediated, in part, by activation of Rac Sulciner et al., 1996) . Rac1(12V) activation of NF-kB was found to be independent of JNK activation. Instead, Rac1 stimulated increased production of superoxides and other reactive oxygen species (ROS), and inhibitors of their production also inhibited NFkB activation (Baeuerle and Baltimore, 1996) . Inhibition of either ROS production (Irani et al., 1997) or NF-kB activation (Finco et al., 1997) has been shown to block oncogenic Ras transformation. Furthermore, since NFkB inhibition caused Rastransformed NIH3T3 cells to undergo apoptosis (Mayo et al., 1997) , the role of NFkB activation in Ras, and possibly Rac, transformation may be to cause upregulation of as yet to be identi®ed anti-apoptotic genes. An anti-apoptotic role for NFkB has been described for other extracellular stimuli (reviewed in Baichwal and Baeuerle, 1997) . Whether this is the mechanism by which superoxides promote Ras transformation remains to be determined.
Rho family proteins regulate cell proliferation
Some early indications that Rho family proteins may regulate cell growth include observations that expression of speci®c Rho family proteins is regulated by growth factor stimulation. RhoB was identi®ed as an immediate-early response gene induced by receptor tyrosine kinase activation (EGF and PDGF stimulation), by nonreceptor tyrosine kinases (viral Src and Fps), UV irradiation, and by DNA damaging agents (cisplatin and N-methyl-N-nitrosurea) (Jahner and Hunter, 1991; Fritz et al., 1995) . RhoB was also transiently induced by EGF or TGFa in human mammary epithelial cells and was overexpressed in human breast cancer tissues and cell lines Linares-Cruz et al., 1994) . RhoG gene expression was also found to be growth-inducible (Vincent et al., 1992) . The hematopoietic cell-speci®c Rac2 was induced in T cells by phytohemagglutinin A growth stimulation (Reibel et al., 1991) .
Rho family proteins have also been implicated in cell cycle regulation. RhoA, Rac1 and Cdc42 were shown to be requirement for cell cycle progression through the G1 phase of the cell cycle (Yamamoto et al., 1993; Olson et al., 1995) . For example, C3 toxin treatment and inhibition of Rho function caused Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle and growth inhibition (Yamamoto et al., 1993) . Furthermore, microinjection of constitutively activated mutants of Ras, RhoA, Rac1 and Cdc42 caused G1 progression and stimulation of DNA synthesis in quiescent Swiss 3T3 ®broblasts, whereas the dominant Figure 7 Oncogenic Ras causes transformation by activation of Raf-independent pathways that cause activation of speci®c Rho family proteins. The ability of dominant negative mutants of RhoA, RhoB, Rac1, Cdc42 and RhoG to block oncogenic Ras transforming activity demonstrates the requirement for speci®c Rho family proteins in mediating, in part, Ras transformation. Prevailing evidence suggests that each Rho family protein may function in distinct pathways and that the Cdc424Rac4Rho hierarchy seen for actin reorganization in Swiss 3T3 cells may not occur for Ras transformation of rodent ®broblasts. Rho family proteins contribute to multiple aspects of the transformed and tumorigenic phenotype of Ras-transformed cells negative mutant counterparts blocked serum-stimulated DNA synthesis (Olson et al., 1995) . The mechanism by which Ras and Rho proteins regulate cell cycle progression is not yet understood but it is thought to involve stimulation of D-type cyclins which are stimulated by Ras and AP1 proteins (Albanese et al., 1995) . We recently showed that Rac1 and RhoA stimulated transcription of cyclin D 1 . Rho proteins have also been implicated in the degradation of the cyclin-dependent kinase inhibitor p27 Kip1 , to facilitate entry into S phase . Thus, it is possible that Rho family proteins are mediators of Ras-induced cell cycle progression.
The involvement of BCR, a bifunctional Rho GAP and GEF, as the translocation partner of the Abl tyrosine kinase in Philadelphia Chromosome-positive chronic myelogenous leukemias implicated deregulated Rho protein function in human leukemias. However, whether the BCR sequences present in the p185 or p210 BCR-Abl chimeric proteins contribute to their function as oncoproteins has not been established. Also, although transcripts of the reciprocal Abl-BCR fusion have been detected, whether it encodes a functional protein has not been described. Finally, one Rho family protein (TTF) was rearranged by a t(3 : 4) chromosome translocation in large cell nonHodgkin's lymphomas (Dallery et al., 1995) . What function the hematopoietic cell-speci®c TTF protein may have, and whether its loss of function is important for lymphoma development, has not been addressed.
Direct evidence for the importance of Rho family proteins in the regulation of cell growth came from studies to determine if constitutively activated mutants of various Rho family proteins could cause transformation of rodent ®broblasts. The ®rst evaluation of this possibility did identify a transforming activity for RhoA (Avraham and Weinberg, 1989) . However, transformation of NIH3T3 cells was associated with wild type, rather than activated, RhoA protein. Lacal and colleagues showed that both wild type and constitutively activated Aplysia Rho caused tumorigenic transformation of NIH3T3 cells (Perona et al., 1993) .
Expression of activated mutants of human Rac1, RhoA or RhoB alone have been shown to cause tumorigenic transformation of NIH3T3 and Rat-1 rodent ®broblasts (Qiu et al., 1995a, b; Khosravi-Far et al., 1995; Prendergast et al., 1995) . Constitutively activated Cdc42 has been shown to cause partial transformation of Rat-1 cells (Qiu et al., 1997) . Cdc42(12V)-expressing cells formed colonies in soft agar and tumors in nude mice, but did not show reduced requirement for serum or loss of densitydependent growth in culture. We have found that Cdc42(12V) is growth inhibitory in NIH3T3 cells, but can cooperate with activated Raf to cause focusformation in NIH3T3 assays . Interestingly, Cdc42, but not RhoA or Rac1, has been shown to cause G1 arrest by a p38-dependent mechanism in NIH3T3 cells (MolnaÂ r et al., 1997) .
A recent report also found that overexpression of constitutively activated, GAP-insentive Cdc42(61L) was growth inhibitory in NIH3T3 cells. In contrast, they showed that a mutant of Cdc42 (F28L), which exhibited enhanced GDP/GTP cycling could cause growth transformation of NIH3T3 cells (growth in low serum and soft agar) (Lin et al., 1997) These observations suggested that increased formation of the active GTP-bound protein, together with accelerated GDP/GTP cycling, may both be required to promote Cdc42 transformation. Enhanced GDP/GTP exchange, rather than impairment in GAP-stimulated GTP hydrolysis, has also been shown to activate the transforming potential of Ras proteins (Walter et al., 1986; Feig and Cooper, 1988; Der et al., 1988; Reinstein et al., 1991) .
A growth-regulatory function for other Rho family proteins is also likely. For example, activated RhoG(12V) showed only limited growth transformation of NIH3T3 cells (Roux et al., 1997) . However, it showed strong synergistic focus-forming activity when co-expressed with activated mutants of RhoA, Cdc42 or Rac1. Whether the aberrant upregulation of other Rho family proteins also promote growth transformation remains to be determined. Additionally, whether Rho family proteins can cause growth transformation of epithelial and other cell types has not been addressed.
Rho family proteins promote cell motility and invasion
Rac1, RhoA and Cdc42 function have also been shown to promote cell motility and invasion. Rho protein function was found to be required for crawling movements of NIH3T3 cells on a¯at surface (Takaishi et al., 1993) and for hepatocyte growth factor induced motility of mouse karatinocytes or MDCK epithelial cells (Ridley et al., 1995) . Similarly, C3 treatment showed that Rho is required for LPA-induced invasion of hepatoma cells through a mesothelial cell monolayer (Yoshioka et al., 1995; Wang and Ron, 1996) . C3 treatment inhibited the invasive of three T cell lymphoma cell lines through a monolayer of C3H10T1/2 cells (BW-O-Lil, BW-19 and CCRF-CEM). Invasion in this in vitro assay was shown to correlate with the ability or a cell line to induce experimental metastasis formation in mice (Verschueren et al., 1997) . Collard and colleagues showed that activated Rac1(12V) and the Tiam1 Rac GEF, but not activated RhoA(14V), induced invasion of T lymphoma cells in the same ®broblast invasion assay (Habets et al., 1994; Michiels et al., 1995) . Tiam1 also promoted metastasis in nude mice. Finally, aberrant Rac1 or Cdc42 function increased the motility and invasion in vitro of T47D human breast epithelial cells (Keely et al., 1997) . Both the increased motility and invasion were blocked by inhibitors of PI3K and constitutively activated PI3K alone was sucient to cause these alterations. Thus, PI3K may be a key eector in mediating Rac-and Cdc42-mediated invasion. When taken together with the involvement of Rho proteins in mediating cell attachment and cellcell interactions, Rho regulation of motility and invasion supports the possibility that aberrant function of Rho family proteins promote the invasive and metastatic properties of human tumor cells.
Dbl family proteins: Rho family GEFs and transforming proteins
Finally, the transforming activities associated with many Dbl family proteins also provide evidence that upregulation of Rho family protein function can cause growth deregulation (reviewed in Whitehead et al., 1997) . Dbl family proteins are presumed to cause transformation by causing constitutive upregulation of Rho protein function. Consistent with this, Dbl family proteins cause the same changes in actin organization and gene expression as seen with Rho family proteins (Westwick et al., 1997b) .
All Dbl family proteins share a domain of approximately 180 amino acids that has been designated the Dbl homology (DH) domain. In addition, all family members possess a second, shared domain designated the pleckstrin homology (PH) domain of approximately 100 amino acids (Figure 3) . The PH domain is invariably located immediately COOH-terminal to the DH domain and this invariant topography suggests a functional interdependence between these two structural modules. The DH domain provides the GEF activity and each Dbl family protein may activate a speci®c or several Rho family proteins. Whether the DH domains of some family members actually serve as Rho GEFs remains to be determined (e.g., SOS, RasGRF, BCR).
PH domains are also found in many non-Dbl family proteins that comprise a large, diverse group of proteins that are involved in cell signaling or cytoskeletal functions that requires association with cell membranes (Lemmon et al., 1996) . PH domains can function as protein-protein or protein-lipid interaction motifs and it is generally believed that they serve to recruit proteins to the cell surface by lipid binding. Thus, it is speculated that the PH domain may serve two roles in Dbl family protein function. First, it may promote membrane translocation. This function is supported by the observation of Whitehead and colleagues that addition of a plasma membrane targeting sequence restored the loss of PH function and recreated a transforming version of Lfc (Whitehead et al., 1996) . Second, the PH domain may serve as an intramolecular regulator of the DH domain. Thus, upstream signaling pathways that cause activation of beta-gamma subunits of G proteins or upregulation of phosphatidylinositol lipids may regulate Dbl family protein function via interaction with the PH domain. How Dbl family proteins link extracellular signals with Rho family proteins remains a poorly understood area. Three recent studies showing that speci®c tyrosine kinases cause phosphorylation of Vav to stimulate its GEF activity de®ne one mechanism where extracellular signals cause, via a Dbl family protein, activation of Rho family proteins (Crespo et al., 1997; Han et al., 1997; Teramoto et al., 1997) .
Ras activation of a GTPase cascade: an involvement of Rho family proteins in transformation
While it is clear that Ras must utilize eectors other than Raf, the precise nature of these Raf-independent pathways remains to be fully delineated (Marshall, 1996; Khosravi-Far et al., 1997) . However, several lines of evidence have implicated speci®c Rho family proteins as key downstream mediators of Ras transformation. In retrospect, the early observations that Ras-transformed cells undergo morphologic alterations, loss of stress ®bers and decreased substratum adhesion, and that oncogenic Ras caused increased membrane ruing and motility (Bar-Sagi and Feramisco, 1986) suggested an involvement of Rho family proteins. In this section, we summarize the evidence for a Ras connection with Rho family proteins and discuss our current understanding of how they may contribute to oncogenic Ras-mediated transformation.
One of the ®rst suggestions of a link between Ras and Rho proteins was made by the observation that a p120 GAP-associated protein, p190, is a GAP for RhoA, and to some degree for Cdc42 and Rac (Settleman et al., 1992) . Thus, p120 GAP may serve as an eector that facilitates Ras regulation of Rho family protein function. However, at present, whether the association of a p120 GAP : p190 Rho GAP complex with activated Ras leads to upregulation or downregulation of Rho family protein function has not been established.
Genetic analysis in S. pombe Ras (Ras1) also identi®ed a link with Rho family proteins and de®ned two distinct Ras1 eector-mediated activities. One involves Ras1 interaction with Byr2 which is a MEK kinase homolog Van Aelst et al., 1993; Masuda et al., 1995) . The other involves Ras1 interaction with the Scd1 Dbl family protein (Chang et al., 1994) . Scd1 is a putative exchange factor and activator of the S. pombe Cdc42 homolog. Interestingly, Scd1 was found to bind directly to activated Ras and possess properties of a Ras eector, thus directly linking Ras activation to activation of Rho family proteins. Whether a speci®c mammalian homolog(s) of Scd1 exists and functions as a Ras eector remains to be determined. Finally, this model is an oversimplification since Scd1 is likely to promote a multiprotein complex formation, with the SH3 domain-containing Scd2 protein and GTP-complexed Ras1 (Chang et al., 1994) . Such a role for an eector emphasizes a theme where eectors of small GTPases mediate their actions by promoting the formation of signaling complexes rather than activating simply linear cascades.
Further evidence for the involvement of Rho family members in mediating oncogenic Ras function came from microinjection studies in serum-starved Swiss 3T3 cells by Hall and colleagues . H-Ras(12V) induction of membrane ruing and stress ®bers were blocked by dominant negative Rac1(17N) and C3, respectively. These observations established the ability of oncogenic Ras to transiently stimulate a Rac4Rho cascade and prompted investigations into the possible involvement of RhoA and Rac1 in Ras transformation. Consequently, the morphologic transformation seen in Rastransformed cells may be caused, in part, by deregulation of Rho and Rac function.
Presently, the function of ®ve Rho family proteins have been shown to be important for oncogenic Ras transforming activity. Three experimental approaches have been applied to support key contributions of RhoA, RhoB, Rac1, Cdc42 and RhoG to Ras transformation (Qiu et al., 1995a; Prendergast et al., 1995; Qiu et al., 1995b Qiu et al., , 1997 Roux et al., 1997; Lebowitz et al., 1997) . First, co-expression of dominant negative mutants [equivalent to the Ras(17N) mutant] of each Rho family protein caused a signi®cant, although incomplete, reduction in oncogenic Ras focus-forming activity when analysed in rodent ®broblasts. Second, coexpression of constitutively activated versions of each Rho family GTPase with activated Raf-1 mutants showed cooperative and synergistic focus-forming activity. Finally, constitutively activated mutants caused growth transformation of NIH3T3 or Rat1 rodent ®broblasts. Taken together, these observations support a model where oncogenic Ras causes constitutive activation of speci®c Rho family proteins which in turn activate a spectrum of functions that contribute to full Ras transforming activity. However, it should be emphasized that a demonstration that Ras-transformed cells exhibit constitutively elevated GTP-bound levels of a speci®c Rho family protein has not been determined. Thus, which, if any, of the known Rho family proteins are clearly targeted by oncogenic Ras remains to be established.
The evaluation of eector domain mutant of oncogenic H-Ras also supports the contribution of Rho family proteins to Ras transformation (White et al., 1995; Joneson et al., 1996b; Khosravi-Far et al., 1996) . Speci®cally, two mutants with single amino acid substitutions (37G and 40C) lost the ability to bind and activate Raf and the ERK pathway. Despite this defect, both mutant proteins retained the ability to cause full transformation of NIH3T3 cells (KhosraviFar et al., 1996) . However, the transformed phenotype caused by Ras(12V, 37G) or Ras(12V, 40C) was distinct from that caused by activated Ras or Raf, and instead, was indistinguishable from the transformed phenotype caused by activated Rac or Rho proteins. These observations lend further support for a Raf-independent connection between Ras and Rho family proteins that contributes to cellular transformation.
The evaluation of Ras-transformed rodent fibroblasts that stably co-expressed either dominant activated or negative Rho family proteins has provided some clues regarding the contribution these small GTPases to the Ras transformed phenotype. For example, coexpression of activated Rac1 or RhoA caused further morphologic transformation and decreased attachment to the plastic substratum of Rastransformed NIH3T3 cells . These cells also formed colonies in soft agar that suggested increased motility and invasive properties. In contrast, co-expression of dominant negative Rac1 or RhoA caused a morphologic reversion of Rastransformed NIH3T3 cells . Taken together, these observations support the possibility that Ras causes morphologic transformation, in part, by upregulation of Rac1 or RhoA function. However, the observations that Rac1-and RhoA-transformed NIH3T3 cells do not undergo any signi®cant morphologic transformation, and retain well-organized stress ®bers and focal adhesions, argue that aberrant Rac or Rho function is not responsible for that altered morphology and loss of stress ®bers. Instead, since Raf-and MEK-transformed NIH3T3 cells also undergo morphologic transformation, it suggests that the Raf4MEK4ERK pathway promotes morphologic transformation.
How the transient changes in actin organization caused by Rho family proteins relate to long term changes is also not clear. Ras-transformed NIH3T3 cells do possess enhanced membrane ruing and pinocytosis, consistent with persistent Rac activation. However, the loss, rather than enhancement, of stress ®bers and focal adhesions, are not consistent with persistent Rho activation.
Several observations suggest that each Rho family protein contributes a distinct aspect of Ras transformation. First, constitutively activated mutants of each Rho family protein caused a distinct transformed phenotype in NIH3T3 cells. Second, co-expression of dierent combinations of activated mutants showed cooperative focus-forming activity, suggesting that they activate distinct pathways (Roux et al., 1997) . Interestingly, the greatest cooperative focus-forming activity was seen with co-expression of activated Cdc42(12V) and Rac1(12V). Third, the characterization of Rat1 ®broblasts coexpressing H-Ras(12V) and either dominant negative Rac1 or Cdc42 argued that each Rho family protein played distinct roles in Ras transformation (Qiu et al., 1997) . Dominant negative Cdc42(17N) blocked the soft agar growth and cause morphologic reversion of Ras-transformed Rat-1 cells. However, low serum growth was retained. In contrast, Rac1(17N) reverted low serum growth and colony formation in soft agar, but not morphologic transformation. Hence, it was proposed that Cdc42 and Rac play distinct roles in Ras transformation, with Cdc42 mediating morphological transformation and Rac1 promoting serum-independent growth. Finally, distinct contributions of each Rho family protein to Ras transformation is also suggested by the observation that dominant negative RhoA and Cdc42, but not Rac1, blocked Raf transforming activity. These ®ndings also suggest that the Cdc424Rac4Rho cascade for actin reorganization may not apply for their association with oncogenic Ras transformation. Finally, since dominant negative Rac1 impaired RhoG-mediated transformation, it was proposed that Rac1 functioned downstream of RhoG.
A search for the missing link that connects Ras with Rho family proteins
Although how Ras may connect with Rho family proteins is not clearly understood at present, the prevailing evidence support the linkage via a Rafindependent pathway. First, dominant negative mutants of Rac1, RhoA, Cdc42 and RhoG showed complete, or preferential, inhibition of Ras versus Raf focus-forming activity. Second, the potent cooperative focus-forming activity seen when activated Raf and Rho family proteins are co-expressed suggests activation of distinct signaling pathways. Third, activated Raf does not cause direct activation of JNK, indicating that Rac, Cdc42 and RhoG are not downstream components of this pathway.
The studies presented above clearly establish a critical role for Rho proteins in mediating Rasinduced cytoskeletal alterations, cellular transformation, gene expression and cell cycle progression. However, the components that transmit the signal from activated Ras to Rho proteins remain to be determined. Evidence that support the involvement of known Ras-binding proteins as candidate eectors that link Ras with Rho proteins is summarized in this section.
At least ®ve candidate eectors of Ras display properties that support their possible role in linking Ras to Rho family proteins. First, similar to S. pombe Ras (Chang et al., 1994) , a mammalian Rho GEF that is analogous to yeast Scd1 may function as an eector and directly link Ras with speci®c Rho family proteins. However, although over 20 candidate mammalian Rho GEFs, or Dbl family proteins, have been identi®ed, to date none have been implicated as Ras-GTP binding proteins . Nevertheless, by analogy to Ras proteins, it is anticipated that a Rho GEF will still be an important intermediate between Ras and Rho proteins. Second, Ras interaction with a p120 GAP:p190 Rho GAP complex may lead to activation or inactivation of Rho family proteins (Settleman et al., 1992) . Overexpression of p190 GAP has been shown to cause inhibition of stress ®ber formation (Ridley et al., 1993) . However, it is not known whether Ras association in¯uences p190 Rho GAP function. Indirect evidence for such a role is provided by the recent observation that dominant negative mutants of p120 GAP, block Ras activation of JNKs but not MAPKs . Third, three groups recently identi®ed independently a Ralbinding protein (RalBP1/RLIP1/RIP1) that interacted with Ral in a GTP-dependent manner, required an intact Ral eector domain, and contains a Rho GAP domain (Cantor et al., 1995; Jullien-Flores et al., 1995; Park and Weinberg, 1996) . Thus, this protein may serve as a link between Ras and Rho proteins (Feig et al., 1996) . Ras association with RalGDS may lead to the activation of Ral. Activated Ral then associates with RalBP1/RLIP1/RIP1 and alters the activity of certain Rho family members. This is an intriguing model that remains to be validated. This Ral-binding protein showed strongest GAP activity towards Cdc42, and to a lesser degree with Rac, but not RhoA. Ral association and regulation of RalBP1 GAP activity also has yet to be demonstrated in vivo. Fourth, Ras interaction and activation of MEKK1 may explain how Ras mediates activation of JNK and p38, although this pathway would not be expected to involve a Rho family protein. Finally, while PI3K has been shown to be a candidate eector of Ras by interacting with Ras in a GTPdependent manner, it is also thought to be required for activation of Rac proteins (Hu et al., 1995) . Furthermore, constitutive activated mutants of PI3K activate JNK (Klippel et al., 1996) , although a second study did not see this activation (Marte et al., 1997) . Despite these ®ve possibilities, the exact mechanism by which signals from activated Ras proteins are transmitted to cause activation of Rho family of proteins still remains to be characterized. A direct demonstration that speci®c Rho family proteins are constitutively activated in Ras-transformed cells also remains to be shown. Finally, Marshall and colleagues showed recently that Rho signaling antagonized Ras-induced increases in p21/Waf1/Cip1 levels (Olson et al., 1998) . This suggests that RhoA does not promote a Ras-mediated signaling event, but instead, negatively modulates a Ras-mediated signaling function.
G protein-coupled receptor transformation and Rho family proteins
In addition to the involvement of Rho family proteins in Ras and Db1 family protein transformation, speci®c Rho family proteins also contribute to the transforming actions of other oncogene proteins. For example, a requirement for Rho family protein function has been determined for viral Abl (Renshaw et al., 1996) . Dominant negative Rac1(17N) was shown to block vAbl activation of JNK and cause partial reversion of transformation of NIH3T3 cells (P-3T3 subclone). Serum-independent growth, but not morphologic transformation or anchorage-independent growth were inhibited. Polyoma virus middle T oncoprotein focusformation on F111 ®broblasts was inhibited completely by co-expression of dominant negative Rac1(17N) or Cdc42)(17N) (Urich et al., 1997) . Thus, it will not be surprising if Rho family proteins will be required for the transforming activity of other oncoproteins.
In addition to mediating a spectrum of normal physiological responses that include neurotransmission, metabolism, growth and dierentiation (van Biesen et al., 1996) , there is also emerging and growing evidence for the involvement of aberrant GPCR function in cellular transformation and oncogenesis (Dhanasekaran et al., 1995). As described above, Rho family proteins are components of a number of GPCR receptor signaling pathways. Therefore, it is not surprising that Rho family proteins have been implicated as essential mediators of transformation by some heterotrimeric G proteins (G 12 and G 13 ) and G protein-coupled receptors (Mas and XGR). The following section summarizes the importance of Rho family proteins in their transforming actions.
A number of G protein-coupled receptors (GPCRs; also serpentine receptors, SRs) have been identi®ed as oncogenes in ®broblast transformation assays. A determination that the mas oncogene, detected in an NIH3T3 transfection/nude mouse tumorigenicity assay, encoded a novel G protein coupled receptor provided the ®rst indication that G protein-mediated signaling pathways could promote cellular transformation (Young et al., 1988) . Subsequently, other G proteincoupled receptors have been identi®ed as having transforming properties and include the M 1 -, M 2 -and M 3 -muscarinic acetylcholine receptors (Gutkind et al., 1991) , the 5HT1b serotonin receptor (Julius et al., 1989) , and the a1b-adrenergic receptor (Allen et al., 1991) . More recently, the thrombin receptor (Whitehead et al., 1995) and the XGR novel G proteincoupled receptor (R Kay, unpublished observation) were also added to this list by virtue of their detection as transforming proteins in cDNA library screens for transforming proteins in NIH3T3 transformation assays. We recently found that Mas causes transformation by activation of Rac (Zohn et al., 1997) , whereas XGR causes transformation by activation of Rho (Zohn et al., in preparation) , and it is likely that the transforming activity of other GPCRs will also involve speci®c Rho family proteins.
What G proteins mediate the transforming actions of these GPCRs? At present, this is not known. However, observations that constitutively activated mutants of a number of G protein a subunits can cause transformation of rodent ®broblasts suggests candidates for this role. In particular, constitutively activated mutants of Ga 12 and the related Ga 13 have exhibited the strongest transforming potential and can cause tumorigenic transformation of rodent ®broblasts Vara Prasad et al., 1994; Chan et al., 1993; Jiang et al., 1993; Voyno-Yasenetskaya et al., 1994) . Similarly, Ga q has been shown to transform NIH3T3 cells (Kalinec et al., 1992; De Vivo et al., 1992) . However, Ga q can also be cytotoxic (Kalinec et al., 1992; Wu et al., 1992) , and induces apoptosis (Althoefer et al., 1997) . Since the signaling and transforming activity of Ga 12 and Ga 13 have been shown to involve Rac or Rho function, they represent logical connectors between transforming GPCRs and Rho family proteins. For example, Ga 12 transforming activity was shown to be inhibited by dominant negative RhoA and Rac1, but not Cdc42 (Tolkacheva et al., 1997) . Microinjection analyses of activated Ga 12 and Ga 13 in Swiss 3T3 cells caused the induction of stress ®bers (Buhl et al., 1995; Hooley et al., 1996) and both have been shown to activate JNK (Prasad et al., 1995; Collins et al., 1996) . Recently, the demonstration that Ga 13 can interaction with and activate the Lsc/ p115 RhoGEF Dbl family protein, a Rho GEF, de®nes at least one possible link between GPCRs and Rho (Hart et al., 1998) .
In summary, the transforming actions of diverse oncoproteins, ranging from Ras to G protein-coupled receptors, require the function of speci®c Rho family proteins. Thus, it is likely that speci®c Rho family proteins will play key supportive roles in human carcinogenesis. Whether mutational activation, or abberant overexpression, of speci®c Rho family proteins alone occur in human cancers will be an important goal of future studies.
Rho family proteins mediate their actions through interaction with multiple eectors
Clearly, Rho family protein-mediated changes in actin cytoskeletal organization, gene expression and regulatin of cell cycle progression are all likely to contribute to the aberrant growth phenotype of Ras-transformed cells. However, what aspects of their function, mediated by which eectors, contribute to Ras transformation are presently not understood. One approach for addressing this question has been to determine what promotes the transforming activity of speci®c Rho family proteins. This process is complicated by the multitude of functions attributed to each Rho family protein and the fact that, like Ras, each mediates its actions through a plethora of eector targets. As with Ras, it is suspected that no one speci®c eector will be important for the growth-promoting actions of a speci®c Rho family protein.
The roster of candidate eectors for Rac1, RhoA and Cdc42 is extensive and continues to expand. Whereas the discovery of binding partners has been rapid, progress in de®ning their contributions to Rho family protein function has been very limited. In the following section, we provide a brief overview of Rho family binding proteins and possible functions. We also summarize observations from recent studies using eector domain mutants of Rac1 and Cdc42 that begin to de®ne the precise function of speci®c Rho family GTPase eectors. Finally, we conclude with a discussion of how a spectrum of structurally and functionally diverse proteins all share the common property of serving as eectors of a particular Rho family protein.
We have categorized Rho family protein binding partners into two general groups based on their binding speci®cities: (1) those that bind Rac and/or Cdc42, but not Rho and (2) those that bind Rho. However, exceptions exist and include proteins that bind Rho and Rac/Cdc42. It should be emphasized that many of these analyses have been limited to the analyses of interaction with Rac1, RhoA or Cdc42. Therefore, possible eector interactions with other Rho family members may complicate these simple classi®cations.
Many of the binding analyses have been performed in vitro or by using yeast two-hybrid binding analyses. Thus, whether they represent physiologically-relevant interactions remain to be determined for many of these proteins. What properties are required to validate an eector? First, the ability of a particular small GTPase to bind to an isolated domain in vitro may be misleading. Therefore, can interaction with the full length protein needs to be established in vivo? Second, does association lead to regulation, positive or negative, of eector function? Third, does overexpression of eector function mimic any aspect of the function of its corresponding GTPase provides?
A plethora of candidate eectors of Rac and Cdc42
Unlike the situation with candidate eectors of Ras, at least three clear consensus binding sequences for Rho family binding proteins have been identi®ed for at least some of these proteins. Hall and colleagues have described a minimal region of 16 amino acids required for binding of Cdc42 and/or Rac, designated the Cdc42/Rac Interactive Binding (CRIB) motif (Figure 8a ). Using this motif in a search of the GenBank data base, they identi®ed more than 25 proteins from a wide variety of eukaryotic species that contain the CRIB motif. This motif is found in known Cdc42/Rac-binding proteins, such as the three p21 (Cdc42/Rac) activated kinase (PAKs) isoforms and the two ACK nonreceptor tyrosine kinases. Other mammalian CRIB motif-containing proteins include WASP, several mixed lineage kinases (MLK2, MLK3), and an uncharacterized human protein MSE55. Further analyses demonstrated that all showed GTP-dependent interaction with Cdc42 and/or Rac1. Therefore, the CRIB motif may de®ne a GTP-dependent interaction site found in a subset of Rac and/or Cdc42 eector molecules.
Generally, Rac and Cdc42 share a number of common binding partners which do not bind RhoA, which may be related to the higher sequence homology between Rac and Cdc42 compared to RhoA. However, some Rac-speci®c-(e.g., p67
phox and POR-1) and some Rac/Cdc42-binding proteins have been identi®ed that lack the CRIB motif (e.g., pp70 S6 kinase, the p85 subunit of PI3K, IQGAPs). Clearly, Rac-binding motifs other than the CRIB motif will be found.
Among the Rac/Cdc42-binding proteins that have been identi®ed, the three mammalian PAK serine/ threonine kinase isoforms (rat a-PAK/human hPAK-1, rat p65 b-PAK/mouse mPAK3 and p62 g-PAK/human h-PAK2) have attracted the most interest (Manser et al., 1994 Teo et al., 1995; Bagrodia et al., 1995b; Martin et al., 1995) . By virtue of their striking homology with the S. cerevisiae protein Ste20, which is implicated in G protein-associated pheromone signaling to a MAPK cascade, PAKs have been considered likely candidates for eectors that promote Rac/Cdc42 activation of the JNK MAPK cascade (Simon et al., 1995; Zhao et al., 1995) . Support for this possibility was provided by experiments using Xenopus oocyte extracts, where Ste20, a related protein from S. pombe (Shk1) and PAK were shown to activate JNK/ SAPK . Additionally, the intrinsic kinase activity of PAKs was activated by Rac/Cdc42-binding (Manser et al., 1994) , and overexpression or constitutive activation of PAK showed enhanced activation of JNK or p38 (Zhang et al., 1995; Frost et al., 1996) . Furthermore, dominant negative mutants of PAK inhibited Rac1 activation of JNK/p38 (Zhang et al., 1995) or of the c-Jun-responsive element in the collagenase promoter (Osada et al., 1997) .
However, other evidence argues that PAKs are not eectors for Rac/Cdc42 activation of JNK. First, Westwick et al., recently identi®ed Rac eector domain mutants that no longer bound to, or activated, PAK, yet they retained the ability to activate JNK and p38 . This demonstrated that PAK was not required for Rac activation, of JNK. Second, Gutkind and colleagues suggested that MLK3 linked Rac/Cdc42 to JNK (Teramoto et al., 1996a) . MLK3 (also known as PTK1 or SPRK) is a member of a family of related kinases (including MLK1, MLK2/ MST, and MUK/DLK/ZPK) of unknown function. MLK3 RNA is expressed in most tissues and cell lines (Ezoe et al., 1994; Ing et al., 1994) . These investigators found that MLK3 associated with activated Rac1 and Cdc42, but not RhoA, in vivo, and co-expression of MLK3 (and not PAK) caused a synergistic enhancement of Rac1 and Cdc42 activation of JNK (Teramoto et al., 1996a) . Overexpression of MLK3 (or MLK2) alone caused activation of JNK, but not p38 or ERK (Tibbles et al., 1996; Hirai S-I et al., 1997) . Thus, MLK2/3, rather than PAKs, may serve as Rac/Cdc42 eectors that lead to activation of JNK. However, Hall and colleagues described evidence that MLK2/MLK3 were not eectors for Rac activation of JNK (Nagata et al., 1998) .
MEKK1 and MEKK4 represent additional candidates for the MAPKKK that links Rac/Cdc42 with JNK (Gerwins et al., 1997; Fanger et al., 1997) . MEKK1 was found to interact with Rac and Cdc42, but not RhoA, in a GTP-dependent fashion in vitro. In contrast, MEKK4 associated with both GDP-and GTP-bound Rac1 and Cdc42 in vitro. MEKK4, but not MEKK1, contains a modi®ed CRIB motif. Kinaseinactive mutants of MEKK1 and MEKK4 both blocked Cdc42 and Rac activation of JNK, and both were activators of JNK, but not p38, in COS cells. In contrast, a second study evaluating a human homolog of MEKK4 suggested that it was not a mediator of Rac or Cdc42 activation of JNK and furthermore, that it was an activator of primarily p38, rather than JNK (Takekawa et al., 1997) . The basis for these discrepancies is presently not clear.
Rac eector domain mutant studies also eliminated PAK as the eector for directing Rac activation of SRF or for transformation of NIH3T3 cells (Westwick et al., 1997a) and well as for induction of lamellipodia (Lamarche et al., 1996; Joneson et al., 1996a; Westwick et al., 1997) . Instead, a correlation was found that implicated PAK as a possible eector for mediating Rac stimulation of transcription from the cyclin D 1 promoter . However, Lamarche et al. (1996) found that PAK was dispensable for Racmediated progression through G1. Thus, Rac upregulation of cyclin D 1 alone may not be sucient for its regulation of cell cycle progression. Furthermore, the Rac-induced pathways leading to the regulation of lamellipodia, activation of JNK, SRF and cyclin D 1 appear to be mediated by distinct eectors . Which, if any, of the known Rac functions are important for Rac transformation, and hence, Ras transformation, is presently unresolved. Finally, RhoB activation of SRE was retained in a nonprenylated mutant that was impaired in transforming activity, indicating that SRE activation alone is not sucient for transformation (Lebowitz et al., 1997) .
Eector mutants of Rac and Cdc42 have also uncoupled JNK activation from regulation of cytoskeletal changes and G1 cell cycle progression. Y40C mutants of Rac and Cdc42 showed impaired binding to PAK and other CRIB motif-containing proteins (e.g., WASP), but Rac1(40C) did retain interaction with the non-CRIB motif-containing proteins p67 PHOX or p160 ROCK. However, since the Y40C mutants of Rac1 and Cdc42 retained wild type abilities to induce actin reorganization, CRIB motif-containing eectors are not likely to be mediators of actin reorganization nor are they involved in linking Cdc42 to Rac or Rac to Rho. Activated PAK can cause changes in actin a organization, but in a way distinct from those caused by Rac1 or Cdc42 (Manser et al., 1997; Sells et al., 1997) . Furthermore, since Y40C mutants of both Rac and Cdc42 also retained the ability to stimulate DNA synthesis, CRIB motif-containing eectors may not be involved in regulating Rac-or Cdc42-induced G1 progression. Finally, since a F37A mutant of Rac1(61L) showed impaired p160 ROCK binding, and lost the ability to stimulate lamellipodia and DNA synthesis, it supports a role for ROCK as an is shared by some, but not all, Rac and/or CDC42-binding proteins. CRIB sequences of MEKK4 (Gerwins et al., 1997) and Ack-2 (Yang and Cerione, 1997) and those previously reported by Burbelo et al. (1995) were aligned using ClustalW and shaded using Boxshade 3.2 (Thompson et al., 1994) . Residues that are conserved in greater than 50% of sequences at a given sequence position are colored blue, while residues that are similar are colored yellow. R, rat; M, mouse; H, human; Sc, S. cerevisiae, Sp, S. pombe; C, C. elegans; B, bovine; D, Drosophila; As, Ascaris. The domain structure of several known RhoA-binding proteins can be grouped into two distinct classes that share sequence similarity in their minimal Rho binding sequences. (b) The class I Rho eector binding motif (REM-1) is shared by the PKN/PRK1 and PRK2 serine/threonine kinases and a novel protein that lack kinase domains (Rhophilin). Shown for PKN/PRK2 are: three predicted homologous coiledcoil (CC) domains referred to as homologous regions 1a, 1b and 1c (HR1a, HR1b, HR1c), (2) a V o /HR2 domain that shows homology between PKN and PRK2 and highly similar to sequences surrounding the NH 2 -terminal V o and pseudosubstrate sites of PCKe and PKCZ and (3) the COOH-terminal kinase domain. The Rho binding sequence (shaded region) is located in the NH 2 -terminal CC domain of PKN/PRK2 and Rhophilin. The multiple sequence alignment of class I REM shows a highly conserved sequence followed by a heptad repeat and are indicated by a solid square (&). The ®rst position of the heptad repeat is not predicted to be present in Rhophilin. Strictly conserved residues are indicated with an asterisk (*) and positions of very high amino acid similarity are indicated by a period (.); (c) Proteins containing the class II REM-2 motif include Rho-kinase, p160 ROCK and ROKa/b. These related kinases possess an NH 2 -terminal kinase domain, followed by a predicted large central coiled-coil (CC) domain and a pleckstrin homology (PH) domain that encompasses a cysteine-rich domain (CRD). The Rho binding sequence (shaded box) is located COOH-terminus of the central CC domain. The multiple sequence alignment of Rem-2 motifs contain a region of strict sequence conservation and are indicated by an asterisk (*). Citron shows a similar domain structure to Rho-kinase, p160 ROCK and ROKa/b. The NH 2 -terminal half of the protein contains a large (*875 residues) predicted coiled-coil (CC) domain. Like the other class II proteins, the CC domain is followed by CRD and PH domains. Citron also contains a proline-rich site (PR) that is a putative SH3 domain binding motif. The putative Rho-binding sequence (shaded box;
) is found in the extreme COOH-terminus of the CC domain. Apart from similarities in domain structure, no strong sequence homology was observed between the Citron and the Rem-1 or Rem-2 motif-containing proteins eector for these two Rac functions. Further mutagenesis of Rac and Cdc42 may identify mutants that will de®ne the contribution of other eectors to the function of Rac and Cdc42.
A role for PAK in Ras and Rac transformation has been suggested by two dierent groups. First, Field and colleagues showed that kinase-de®cient mutants of PAK could block oncogenic Ras transformation (Tang et al., 1997) . However, since mutation of the CRIB motif did not abolish this inhibition of Ras transformation. The inhibition was not likely to be due to formation of nonproductive complexes with Rac or Cdc42. Interestingly, this antagonism of Ras was seen in Rat1, but not NIH3T3 cells. A second study showed that expression of the CRIB motif-containing fragment of PAK could reverse both Ras and Rac1 transforming activity in NIH3T3 cells (Osada et al., 1997) . Since this mutant PAK also blocked Ras and Rac activation of a c-Jun-responsive promoter element (TRE), it was proposed that titration of Rac and/or Cdc42 was responsible for inhibition of Ras transformation.
The 70 kDa S6 kinase (p70
S6K
) also appears to be an important eector of Rac and Cdc42 function. p70 S6K is activated by diverse mitogenic stimuli, including growth factors, cytokines and activated oncogenes (Chou and Blenis, 1995) . Present evidence supports an important role for p70 S6K in the progression of cells from the G 1 to S phase of the cell cycle. Chou and Blenis (1996) showed that catalytically inactive p70 S6K interacted with GTP-complexed Rac1 and Cdc42, but not RhoA, in vitro (Chou and Blenis, 1996) . Constitutively activated mutants of Rac1 and Cdc42, but not RhoA, stimulated p70 S6K activity in vivo. Eector domain mutations abolished this activity. Dominant negative Cdc42(17N) or Rac1(17N) blocked EGF-and PDGF-induced activation of pp70
. Similar to the Ras:Raf interaction, Cdc42 association with p70 S6K in vitro alone did not activate its kinase activity. Thus, Cdc42/Rac interaction with p70 S6K must facilitate subsequent events that lead to full kinase activation in vivo. It is presently not known what aspect of Rac function is mediated by p70 S6K . Rac1 and Cdc42 have been shown to complex the p85 subunit of PI3K in vitro and to co-precipitate with PI3K activity in vitro and in vivo (Zheng et al., 1994a; Tolias et al., 1995) . No CRIB motif is present in the p85 subunit. This interaction was found to be GTPdependent and a Cdc42(35A) eector domain mutant showed impaired p85 binding (Zheng et al., 1994a) . Cdc42 stimulated the activity of immunoprecipitated PI3K 2 ± 4-fold. Thus, although the sequence homology of p85 with other Rho GAPs (e.g., BCR, N-chimaerin and p190 Rho GAP) suggested that it acted as a negative regulator of Rho function, no GAP function has been demonstrated for p85. Instead, this GAPrelated domain may serve to promote PI3K association with Rac/Cdc42 as an eector in regulating reorganization of the actin cytoskeleton (Zheng et al., 1994a) . Interestingly, another Rho GAP (N-chimaerin) has also been shown to exhibit properties of a Rac/Cdc42 eector that mediates actin cytoskeletal events . PI3K has also been implicated as an eector of Ras. However, it is the p110 catalytic subunit that complexes with Ras-GTP (Rodriguez-Viciana et al., 1994 . PI3K functions as a lipid kinase and its phosphorylated phosphoinositides can interact and regulate a wide variety of protein targets, including a number of proteins that regulate actin assembly (reviewed in Toker and . Since the oncogene responsible for the transforming activity of the avian sarcoma virus 16 in chicken embryo ®broblasts encodes the p100 catalytic subunit chicken PI3K (Chang et al., 1997) , upregulation of PI3K activity may contribute to Ras and Rac growth transformation.
Two Rac-binding proteins have been implicated in mediating Rac regulation of the actin cytoskeletal organization. In one study, Van Aelst and colleagues used yeast two-hybrid screening and identi®ed a partner of Rac1(POR1) protein that interacted with GTP-complexed Rac1, but not Cdc42, RhoA or H-Ras . The 34 kDa POR1 protein showed no signi®cant sequence identity with any known proteins and no conserved motifs besides the presence of a putative leucine zipper motif. The Rac1(35A) eector domain mutant that is impaired in membrane ruing also showed impaired binding to POR1. Truncated POR1 inhibited Rac1(12V)-induced membrane ruing, whereas full length POR1 acted to synergistically enhance activated H-Ras(12V) membrane ruing activity. However, no synergistic interaction was seen between Rac1 and POR1. Finally, POR1 may also serve as an eector for another small GTPase ARF6 and mediate related changes in actin cytoskeletal organization in CHO cells (D'Souza-Schorey et al., 1997). ARF6 also regulates endocytic tracking. Thus, together with RhoD, it provides further functional links between actin cytoskeleton reorganization and membrane tracking.
In another study, yeast two-hybrid library screening with activated RhoA(63L) isolated a previously identi®ed RhoA-binding protein, p160
ROCK , that also interacts with activated forms of Rac1 and Cdc42, but not R-Ras (Lamarche et al., 1996) . Since the Rac1(37A) eector domain mutant no longer interacted with ROCK and failed to induce lamellipodia or G 1 progression, it suggested that ROCK may mediate these two activities of Rac1.
The Wiskott ± Aldrich syndrome (WAS) protein (WASP) contains the CRIB motif and was identi®ed as a Cdc42-binding protein that bound weakly to Rac1, but not RhoA AspenstroÈ m et al., 1996; Kolluri et al., 1996) . The WASP gene is mutated in WAS patients. These WAS-aected patients possess an X-linked recessive disorder characterized by thrombocytopenia, which is characterized by recurrent infections due to T and B cell function and eczema. Abnormalities seen in T and B cells suggested defects in the organization of the actin cytoskeleton . WASP overexpression caused the formation of WASP clusters that were highly enriched in polymerized actin in porcine aortic endothelial cells and clustering was inhibited by dominant negative Cdc42(17N), but not Rac1(17N) . Additionally, co-expression of WASP inhibited Cdc42(12V) and Rac1(12V) induced changes in actin cytoskeleton organization. Furthermore, a region of homology between WASP and other proteins (VASP and Mena) that are involved in the organization of actin cytoskeleton and control of micro ®lament dynamics has been identi®ed (Gertler et al., 1996) . Interestingly, this domain in VASP and Mena has been shown to interact directly with components of focal adhesions. These results implicate WASP as an eector that mediates the activity of Cdc42/Rac in F-actin polymerization and reduced WASP expression may contribute to the cytoskeletal abnormalities seen in WAS aected males (Kolluri et al., 1996) . Genetic evidence supporting this link comes from analyses of the yeast counterpart of WASP, designated Bee1p. Bee1p is a component of the cortical actin cytoskeleton and plays an essential role in the organization of actin ®laments (Li, 1997) . Bee1 null cells possess altered actin organization and are defective in budding and cytokinesis. However, since Bee1 lacks a CRIB motif, its functions may be distinct from those of human WASP. Finally, since a Cdc42 eector mutant that lacked WASP binding still stimulated lamellipodia formation, WASP is clearly not the eector to mediate this Cdc42 eect (Lamarche et al., 1996) .
Interestingly, WASP is also recognized by the Nck adaptor protein, via its Src homology 3 domains (Rivero-Lezcano et al., 1995; Quilliam et al., 1996) , and Nck also complexes with other Rho family binding proteins (PAK1, PAK3 and PRK2) (Bagrodia et al., 1995b; Quilliam et al., 1996; Bokoch et al., 1996; Galisteo et al., 1996) . Nck associates with activated receptor tyrosine kinases (Li et al., 1992; Lee et al., 1993) . Therefore, it may serve as an adaptor that links extracellular stimuli to Rho family proteins.
IQGAP1, and the closely-related IQGAP2 (62% identity), have been shown to bind Rac1 and Cdc42, but not RhoA (Brill et al., 1996; Kuroda et al., 1996) . No CRIB motif is present in these proteins. IQGAP was identi®ed originally as a human protein that harbored potential calmodulin binding IQ motifs upstream of a sequence related to the catalytic domain of Ras GAPs (Weissbach et al., 1994) , and was isolated independently by anity chromatography analyses for GTP-dependent Cdc42-binding proteins (Kuroda et al., 1996) . Whereas IQGAP1 RNA was found highly expressed in lung, kidney and placenta, IQGAP2 was observed to be expressed predominantly in the liver (Brill et al., 1996) . Although both proteins show strong homology with the Ras GAP of S. pombe, no stimulation of Ras, Rac1 or Cdc42 GTPase activity has been detected (Brill et al., 1996; Kuroda et al., 1996) . Since IQGAPs harbor a potential actin binding domain, and were found to be accumulated at insulinor Rac1-induced membrane ruing areas, it was postulated that IQGAPs may serve as eectors that mediate the actin cytoskeletal events of Cdc42 and Rac1 (Kuroda et al., 1996) . Consistent with this possibility, it was found that Cdc42 and IQGAP1 formed a stable complex in vivo along with F-actin (Erickson et al., 1997) . EGF stimulation also promoted formation of Cdc42:IQGAP1 complexes in COS cells, suggesting that growth factor stimulation may promote an IQGAP1-mediated link between Cdc42 and the actin cytoskeleton. Finally, additional modes of IQGAP regulation are suggested by evidence that calmodulin and calcium caused disruption of Cdc42:IQGAP1 interaction in vitro (Joyal et al., 1997) .
Other candidate eectors of Rac include ROKa, a previously described RhoA-binding protein (Leung et al., 1996b) , POR-2, a protein of unknown function , and tubulin .
Citron is a protein of unknown function that was identi®ed as a RhoC-binding protein in a yeast twohybrid library screen, and found to bind to Rac1, but not Cdc42, in vitro (Madaule et al., 1995) . The interaction of Citron with two functionally distinct small GTPases does not necessarily indicate a common function for Citron. It is possible that interaction with Rac and Rho may cause distinct subcellular locations of Citron, or form distinct, signaling complexes, to cause distinct downstream events. Narumiya and colleagues have recently described a splice variant of Citron that contains an N-terminal Ser/Thr protein kinase domain that has *50% sequence identity to the kinase domains of ROCK, ROK and MDK that are discussed below (Madaule et al., 1998) . Designated Citron-K, this widely expressed form may mediate Rho regulation of cytokinesis. Messenger RNA encoding the previously discovered Citron variant (designated Citron-N) was detected only in brain tissue.
The 120 kDa ACK tyrosine kinase (ACK-1) speci®cally interacts with Cdc42 and not Rac or RhoA. In addition to its kinase domain, ACK also has an SH3 domain, a CRIB motif, and a proline-rich C-terminus which may represent putative SH3 domain binding sites. To date, little is known regarding the role of ACK-1 as a Cdc42 eector. Recently, a 96 kDa ACK-2 nonreceptor tyrosine kinase that shares the same structural features with ACK and exhibits speci®c interaction with GTP-bound Cdc42 was identi®ed (Yang and . The reduced size of ACK-2 is due primarily to the absence of sequences related to those present in the N-and C-terminal regions of ACK-1. ACK-2 transcripts were detected in a wide variety of human tissues, with highest levels seen in brain and skeletal muscle tissue. Co-expression of Cdc42(61L) and ACK-2 in COS cells caused increased ACK-2 autophosphorylation. Furthermore, the coprecipitation of the two proteins supports that possibility that ACK-2 is a physiologically relevant eector for Cdc42. ACK-2 autophosphorylation was stimulated by attachment as well as by EGF or bradykinin stimulation. Thus, ACK-2 may mediate the actions of Cdc42 in response to diverse extracellular stimuli.
The yeast two-hybrid screening of an Epstein ± Barr virus-transformed B-cell library that identi®ed WASP also identi®ed a second Cdc42-binding protein (AspenstroÈ m, 1997) . Designated CIP4, this 545 amino acid protein lacks a CRIB motif and shows sequence homology with a number of proteins that serve as regulators of actin organization (e.g., RhoGAP). Binding to Cdc42 was GTP-dependent, and no binding was seen to Rac1-GTP. Overexpression of CIP4 caused a reduction in stress ®ber formation and co-expression of Cdc42(61L) caused a clustering of CIP4. Thus, CIP4 may interact with Cdc42 in vivo to regulate actin organization although it does not appear to mediate Cdc42 induction of ®lopodia.
In summary, there exists multiple candidate eectors of Rac and/or Cdc42 function and more are likely to be identi®ed. The existence of Rac/Cdc42-binding proteins that lack the CRIB motif indicates that at least two, if not more, Rac-and/or Cdc42-binding motifs will be identi®ed. Currently, it is not clear, which, if any, of these Rac-binding proteins are physiologically relevant eectors. Furthermore, which eectors mediate Rac/Cdc42 regulation of actin organization, gene expression and regulation of cell proliferation and invasion remain to be characterized. With regards to transformation, our recent evaluation of Rac eector domain mutants failed to implicate any known Rac1 function with transforming potential (Westwick et al., 1997a) . One interpretation is that multiple pathways promote Rac growth regulation and that no one pathway alone is necessary. Alternatively, it suggests that some as yet undiscovered Rac function is responsible for Rac-mediated transformation. Regardless of which is the correct scenario, it remains to be de®ned what Rac function(s) is required to promote oncogenic Ras transformation. Finally, despite their signi®cant number of shared eectors, it is clear that Rac1 and Cdc42 are functionally distinct proteins. For example, human Cdc42, but not Rac1 or Rac2, can restore a Cdc42Sc defect in S. cerevisiae (Shinjo et al., 1990 ). Furthermore, as described above, the transforming functions of Rac1 and Cdc42 are quite distinct.
A plethora of candidate eectors of Rho
A growing number of Rho-binding proteins have also been identi®ed. Two distinct Rho-binding sequence motifs have also been described for a subset of Rhobinding proteins (Reid et al., 1996; Fujisawa et al., 1996) . Both Rho eector binding motifs are distinct from the CRIB motif and are associated with proteins that contain predicted coiled-coil (CC) domains (Cohen and Parry, 1994) . These CC domains may provide the basis for the multimerization of these proteins with Rho and other signaling molecules in a complex with Rho.
Two closely related serine/threonine kinases that show strong sequence similarity to the kinase domain of PKCs (PKN/PRK1 and PRK2), and two novel proteins lacking kinase domains (Rhotekin and Rhophilin), appear to share a distinct Rho eector binding motif (designated class I, REM-1) (Figure 8b ). PRK1 and PRK2 (58% amino acid identity) were identi®ed originally by a PCR-mediated approach to identify sequences that encoded novel PKC-related human proteins (Palmer et al., 1995) . The encoded 120 ± 130 kDa proteins identi®ed by this approach contain an NH 2 -terminal basic sequence encompassing GAXN (a putative pseudosubstrate domain), a REM-1 Rho-binding sequence, followed by amphipathic helix and leucine zipper domains, and a COOH-terminal kinase domain (Figure 8b ). Unlike PKC, neither are regulated by phorbol esters or calcium. Both PRK1 and PRK2 show broad tissue expression.
The 71 kDa Rhophillin protein also contains an NH 2 -terminal Rem-1 binding motif. However, it lacks a kinase domain or any other known catalytic sequences. Aside from the NH 2 -terminal Rem-1 motif, two proline-rich motifs and putative SH3-binding domains are present in the COOH-terminus. Thus, Rho-binding proteins with class I binding motifs also typically contain other putative protein-protein or protein-lipid binding motifs, suggesting that these eectors may serve to promote targeting and/or multi-protein complex formation with Rho proteins. PRK1 was identi®ed independently by anity chromatography analysis for RhoA-binding proteins and designated protein kinase N (PKN) . Interestingly, LPA resulted in a Rhodependent activation of PKN/PRK1 supporting a role for this kinase in mediating Rho function. The observation that staurosporine, a potent inhibitor of PKC (and possibly PKN/PRK1), blocked formation of focal adhesions suggests that PKN may indeed mediate this action of Rho proteins. Additionally, PKN has been shown to interact with and phosphorylate the head-rod domain of neuro®lament proteins suggesting its role in the regulation of neuro®lament protein assembly (MoÈ sch et al., 1996) . Hence, PKN may be a potential mediator of the growth factor-induced stimulation of intermediate ®laments.
PRK2 was independently isolated by two groups searching for Nck-or RhoA-interacting proteins. First, Quilliam et al. (1996) isolated PRK2 using an expression library screen for proteins that bound to the SH3 domains of the Nck SH2/SH3 adaptor protein . It was also shown to bind RhoA, but not Rac1 or Cdc42. In vitro and co-expression of PRK2 with activated RhoA caused synergistic enhancement of RhoA-dependent activation of SRF expression. Vincent and Settleman (1997) puri®ed PRK2 (and PKN) by anity chromatography with RhoA from rat liver extracts. However, they found that COS cellexpressed PRK2 interacted with GTP-bound Rac1, but interacted with, and activated, both RhoA-GTP and RhoA-GDP. They also showed that a kinase-defective mutant of PRK2 caused a disruption in actin stress ®bers in NIH3T3 cells. Thus, they suggested that PRK2 may be a common eector of both Rac and Rho. The reason for the dierences seen in these two studies is not known. Finally, PKN/PRK1 and PRK2 were also identi®ed independently as liver protease-activated kinases 1 and 2, respectively (Yu et al., 1997) .
Rhophilin, and to a lesser degree Rhotekin, share NH 2 -terminal sequence homology with the PKN/PRK1 and PRK2 Rem-1 motif. Rhotekin was identi®ed by yeast two-hybrid screening for RhoC-binding proteins (Reid et al., 1996) . It also interacted with GTPcomplexed RhoA and RhoB, but not Rac1 or Cdc42. Rhophilin was isolated by yeast two-hybrid screening of a mouse embryo cDNA library for RhoA-binding proteins . Rhophilin showed strong GTP-dependent interaction with RhoA, little with RhoC, and less with RhoB. It also shares a putative NH 2 -terminal CC with PKN/PRK1 and PRK2.
A family of novel serine/threonine kinases share a distinct, second Rho eector binding motif (designated class II/REM-2) (Figure 8c ). ROKa/Rho-kinase (Leung et al., 1996b) and p160 ROCK /ROKb/ROCK-II (Leung et al., 1996a; Ishizaki et al., 1996) share an NH 2 -terminal kinase domain that has strong sequence identity with the kinase domain of myotonic dystrophy kinase (MDK) , a central putative CC domain and a COOH-terminal PH domain (Mayer et al., 1993) that is split by a cysteine-rich, zincdependent folding domain. Interestingly, the Rho/Rac1 binding protein Citron (Madaule et al., 1995) contains a related NH 2 -terminal CC domain that includes the Rho-binding domain, and a related kinase domain (Madaule et al., 1998) . However, the Rho-binding sequence exhibits weaker sequence homology to the Rem-2 motif present in these kinases. Hence, Citron may possess a Rho-binding element distinct from the class II motif. Both Citron-K and Citron-N also contain a COOH-terminal cysteine-rich motif, a PH domain and a proline-rich, putative SH3-binding motif. Thus, like other Ras and Rho family eectors, Citron may also function as a scaolding protein for Rho.
ROKa was identi®ed in expression screening for RhoA-binding proteins serine/threonine kinase (Leung et al., 1996b) . ROKa showed a cytoplasmic location and co-expression of RhoA(14V) caused an increased association of ROKa with the pellet fraction, suggesting that RhoA promoted its translocation to membranes. Injection of DNA encoding full length ROKa caused the formation of stress ®bers and focal adhesions in HeLa cells (Leung et al., 1996a) . A closely related protein with 64% overall identity to ROKa and 90% identity to the ROKa kinase domain, was subsequently isolated (ROKb; also ROCK-II and p160 ROCK). In vitro binding analyses using puri®ed recombinant proteins showed that both ROKa and ROKb bound RhoA, RhoB and RhoC, but not Rac1 or Cdc42 (Leung et al., 1996a) , although subsequent yeast two-hybrid analysis also showed interaction with Rac1 (Joneson et al., 1996a) and Cdc42 (Lamarche et al., 1996) . Narumiya and colleagues identi®ed p160 ROCK (a Rhoassociated CC domain-containing protein kinase) as a novel RhoA-binding protein serine/threonine kinase that showed 44% identity with the kinase domain of MDK . RhoA was shown to associate with p160 ROCK in vivo and this association promoted weak enhancement of its autophosphorylating activity. Finally, Kaibuchi and colleagues identi®ed the p164 Rho-kinase by anity chromatography analyses for RhoA-GTP binding proteins (Matsui et al., 1996) . Rho-kinase is likely a splice variant of ROKa, since they dier only at their NH 2 -termini, with Rhokinase containing an additional nine amino acids. Since the kinase activities of these proteins showed only limited stimulation by association with RhoA in vitro, it is likely that RhoA binding may facilitate other events that lead to full kinase activation.
Another RhoA-GTP binding protein, myosin light chain (MLC) phosphatase, together with Rho kinase, provides a mechanism for RhoA regulation of stress ®ber formation . The myosin binding subunit (MBS) of MLC phosphatase was identi®ed as a RhoA-binding protein by anity chromatography analysis of bovine brain membrane extracts. RhoA binding and activation of Rho kinase stimulates Rho kinase phosphorylation of MBS. This results in the inactivation of myosin phosphatase activity, leading to activation of myosin through a net increase in MLC phosphorylation by other protein kinases. MLC phosphorylation has been shown to induce a conformational change in myosin, which increases its binding to actin ®laments, causing ultimately the formation of stress ®bers (Chrzanowska-Wodnicka and Burridge, 1996) . Rho-stimulated contraction of ®broblasts was blocked by the MLC kinase inhibitor (KT5926), resulting in decreased MLC phosphorylation and loss of stress ®bers and focal adhesions. Additionally, Rho kinase can also phosphorylate MLC at the same sites that are phosphorylated by MLC kinase . Finally, current evidence indicates that RhoA causes stress ®bers and focal adhesion through distinct pathways (Chrzanowska-Wodnicka and Burridge, 1996) . The COOH-terminal sequences of MBS that bind to RhoA share structural similarity (polybasic region followed by leucine zipper-like motif) with PKN/PRK1. However no detectable Rem-2 motif was observed .
Another eector that may link Rho with the actin cytoskeleton involves members of a formin-related family of proteins that include the S. cerevisiae Bni1p, the Drosophila Diaphanous and Cappuchino proteins, and the mammalian Bnip1 homolog p140mDia (Castrillon and Wasserman, 1994; Emmons et al., 1995; Peterson et al., 1995; Marhoul and Adams, 1995) . Bni1p and the related Bnr1p regulate the eects of Rho proteins on actin organization. p140mDia can interact with mammalian RhoA-GTP and pro®lin. Furthermore, p140mDia, pro®lin and RhoA are colocalized in a Rho-dependent structures such as membrane rues in motile cells, cleavage furrows in mitotic cells, and phagocytic cups induced by ®bronectin (Watanabe et al., 1997) . Thus, p140mDia may mediate actin assembly via a pro®lin-mediated mechanism.
Since Rhotekin and Rhophillin lack known catalytic functions, essentially nothing has been described regarding their functions. At least three possible mechanisms for the function of these proteins can be envisioned. They may either be directly involved in mediating some aspect of Rho function that does not require a catalytic function by promoting their translocation to various components of cytoskeleton, or they may somehow negatively regulate the function of Rho proteins by forming an inactive complex and preventing the accessibility to other downstream eectors. Another possible function is that they may act as scaolding proteins that regulate the coordinate activities of Rho proteins and their downstream eectors in a multimeric structure.
Observations that stimulation by G protein-coupled receptor agonists that activate Rho (LPA and thrombin), or C3 treatment to block Rho function, of undierentiated neoronal cells (N1E-115, NG108-15 and PC12 cells) have implicated Rho proteins in causing growth cone collapse, retraction of developing neurites, and transient rounding of the cell body (Mackay et al., 1995; Luo et al., 1996) . One recently identi®ed RhoA-binding protein, designated p116 RIP , showed the same activity as C3 or dominant negative RhoA when overexpressed in N1E-115 cells. Although p116 RIP showed preferential binding to RhoA-GTP in yeast two-hybrid binding analyses, in vitro binding analyses showed equivalent binding to either GDP-or GTP-bound RIP is a novel protein that contains a PH domain, two putative SH3 domainbinding sites and a CC region. It was identi®ed in a yeast two-hybrid screen for RhoA-binding proteins, together with a novel RhoGDI (RIP1-RhoGDI2), a novel Db1 family protein (RhoGEF), and another RhoA-GTP binding protein (RIP4) (Gebbink et al., 1997) .
Structural requirements for Rho family protein:eector interactions
The identi®cation of multiple binding proteins strongly suggests that Rho family proteins utilize multiple eector-mediated pathways to cause its diverse array of cellular eects. Like Ras, the regions of Rho family proteins important for eector interaction also appear to be complex. The regions analogous to the core Ras eector sequence (Ras residues 32 ± 40), and¯anking residues are clearly important for all Rho family protein interactions with eectors. Mutagenesis and structural analyses suggest at least two additional, distinct, regions are also likely to mediate interaction with eectors.
There is some evidence that the Rho insert domain may be important for interaction with at least some eectors (Freeman et al., 1996) . Mutations in the Rac1 caused a marked decrease in superoxide production without perturbing p67 PHOX binding, indicating that it was not involved directly in eector binding (Nisimoto et al., 1997) . Instead, it was proposed that it may interact with other components of the NADPH oxidase in neutrophils that was important for activity. In a second study, a Cdc42 mutant protein, where the insert sequence was deleted by replacing it with the corresponding region from H-Ras, retained the ability to activate PAK-3 in vivo and to bind other CRIB motif-containing proteins in vitro (ACK and WASP) (Wu et al., 1997) . However, a reduced anity for interaction from IQGAP1 was seen. Furthermore, while neither GEF or GAP activities were altered, RhoGDI inhibition of GDP dissociation was impaired in the insert mutant of Cdc42. Mutation of the insert domains of Rac1 (Joneson and Bar-Sagi, 1998) , Cdc42 (Wu et al., 1998) , or RhoA (Quilliam LA, unpublished observation) perturb their growth-promoting and/or transforming activites. Thus, de®ning the eector targets that interact with their respective insert domains will delineate the signaling pathways that promote cellular transformation.
Studies with chimeric proteins between Rac1 and RhoA identi®ed a second, COOH-terminal region of Rac1 (residues 143 ± 175) important for Rac eector function. Hall and colleagues showed that both amino and carboxyl terminal regions of Rac1 were required for PAK and p67 PHOX binding, as well as for Racinduced lamellipodia formation (Diekmann et al., 1995) . In agreement with their observations, we also observed that the Rac 73 Rho chimera did not bind PAK or induce lamellipodia, but instead induced stress ®ber formation . Furthermore, we observed a loss of JNK activation, suggesting that the eector required for JNK activation also requires interaction with COOH terminal Rac sequences. Thus, like Ras, the eector-interacting sequences of Rho family proteins are also composed of multiple, distinct sequences.
The importance of sequences beyond switch I and II in interaction with eectors underlines an emerging concept that some small GTPase:eector interactions are not GTP-dependent (e.g., PI5K). Instead, some may be GDP-dependent, others may associate with either GDP or GTP, yet activation may still be GTPdependent.
Future directions
Despite the rapid accumulation of information on Rho family proteins, it is clear that we are only beginning to appreciate the complex nature of their biology and biochemistry. Many questions remain. Will the diversity of cellular processes that involve Rho family proteins continue to increase? Yes, the already outdated nature of this review veri®es that this will be the case. The continued unearthing of yet more Dbl family proteins argues that the diversity of cellular processes that activate Rho family proteins will continue to increase. More Rho family proteins will also be discovered. Thus, the delineation of additional Rho-mediated functions promises to be a major theme for the coming years. Ample evidence from experimental cell systems implicate Rho family proteins as critical components of oncogenic Ras transformation. Do Rho family proteins play such a role in human cancer cells? If so, are Rho-mediated pathways important targets for the development of anti-cancer drugs? What speci®c aspects of Ras transformation are contributed by Rho family proteins?
Understanding the mechanisms of Rho family protein signaling, both upstream and downstream, remains limited. How extracellular signals cause activation of Rho family proteins remains a poorly undestood area. Will Db1 family proteins provide this link? The roster of Rho family binding proteins will continue to expand. Which are physiologically relevant eectors? What is the role of each eector and how is eector utilization is controlled? Our understanding of Rho family signal transduction will continue to evolve. Complex interrelated networks, rather than simply linear pathways, will likely be de®ned. Cell type dierences will continue to add further complexity. In summary, the only thing that seems certain is that evidence will continue to mount, establishing Rho family proteins as key regulators of many cellular processes in normal and neoplastic cells.
